FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter

PMA: P020025 · Supplement: S058 · Decision May 30, 2014
Classifications
1
FEI Numbers
46
Registration Numbers
46

Basic Information

Device Name
Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter
Trade Name
BLAZER II XP, BLAZER PRIME XP, INTELLA TIP MIFI XP TEMPERATURE ABLATION CATHETERS
PMA Number
P020025
Supplement Number
S058
Device Class
FDA Class 3
Product Code
OAD
Generic Name
catheter, percutaneous, cardiac ablation, for treatment of atrial flutter
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
May 30, 2014
Date Received
April 30, 2014
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

ACCEPTANCE TO REPLACE AN EXISTING MANUAL PROCESS WITH AN AUTOMATED PROCESS.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
OAD Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter